1 |
Optical coherence tomography-angiography for monitoring neovascularisations in
macular telangiectasia type 2 |
|
|
| Simone Tzaridis, Kristina Hess, Martin Friedlander, Frank G Holz |
|
| British Journal of Ophthalmology. 2021; 105(5): 735 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Characterization of Idiopathic Choroidal Neovascularization Using Fluorescein Angiography, Indocyanine Green Angiography, and Optical Coherence Tomography Angiography |
|
|
| Atul Kumar, Rajpal Vohra, Surbhi Agrawal, Rohan Chawla, Shorya Vardhan Azad, Pradeep Venkatesh, Anu Sharma |
|
| Ophthalmic Surgery, Lasers and Imaging Retina. 2018; 49(7): 516 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Macular telangiectasia type 2 |
|
|
| Peter Charbel Issa,Mark C. Gillies,Emily Y. Chew,Alan C. Bird,Tjebo F.C. Heeren,Tunde Peto,Frank G. Holz,Hendrik P.N. Scholl |
|
| Progress in Retinal and Eye Research. 2013; 34: 49 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Primitive Retinal Vascular Abnormalities: Tumors and Telangiectasias |
|
|
| Karl Anders Knutsson,Umberto De Benedetto,Giuseppe Querques,Claudia Del Turco,Francesco Bandello,Rosangela Lattanzio |
|
| Ophthalmologica. 2012; 228(2): 67 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2 |
|
|
| Raja Narayanan,Jay Chhablani,Manish Sinha,Vivek Dave,Mudit Tyagi,Rajeev R. Pappuru,Baruch D. Kuppermann |
|
| Retina. 2012; 32(10): 2001 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Monthly Ranibizumab for Nonproliferative Macular Telangiectasia Type 2: A 12-Month Prospective Study |
|
|
| Peter Charbel Issa, Robert P. Finger, Kathrin Kruse, Sönke Baumüller, Hendrik P.N. Scholl, Frank G. Holz |
|
| American Journal of Ophthalmology. 2011; 151(5): 876 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
7 |
INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF PROLIFERATIVE AND NONPROLIFERATIVE TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA : |
|
|
| A Brock Roller, James C Folk, Narendra M Patel, H Culver Boldt, Stephen R Russell, Michael D Abramoff, Vinit B Mahajan |
|
| Retina. 2011; 31(9): 1848 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
8 |
Bevacizumab (Avastin) for the Treatment of Ocular Disease |
|
|
| Jonathan B. Gunther,Michael M. Altaweel |
|
| Survey of Ophthalmology. 2009; 54(3): 372 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II |
|
|
| JACLYN L. KOVACH,PHILIP J. ROSENFELD |
|
| Retina. 2009; 29(1): 27 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II. |
|
|
| KOVACH, J.L. and ROSENFELD, P.J. |
|
| Retina. 2009; 29(1): 27-32 |
|
| [Pubmed] [Google Scholar] |
|
11 |
Bevacizumab (Avastin) for the Treatment of Ocular Disease |
|
|
| Gunther, J.B., Altaweel, M.M. |
|
| Survey of Ophthalmology. 2009; 54(3): 372-400 |
|
| [Pubmed] [Google Scholar] |
|